Ficha del valor · trimestre archivado
MRNA
Moderna, Inc. · Healthcare · Biotechnology
16Tenedores rastreados
—Δ titulares
65.32MAcciones mantenidas
$7.75BValor declarado
+0Nuevas posiciones
−0Cierres
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 147 | +2 | 264.33M | $18.50B | +8 | −5 |
| Q1 2026 | 147 | +3 | 253.55M | $12.87B | +6 | −4 |
| Q4 2025 | 144 | +3 | 257.18M | $7.59B | +5 | −1 |
| Q3 2025 | 18 | +1 | 165.07M | $4.26B | +2 | −2 |
| Q2 2025 | 15 | 0 | 160.48M | $4.43B | +1 | −1 |
| Q1 2025 | 12 | -2 | 69.84M | $1.98B | +1 | −3 |
| Q4 2024 | 14 | -1 | 78.84M | $3.28B | +3 | −4 |
| Q3 2024 | 14 | -2 | 62.86M | $4.20B | +2 | −4 |
| Q2 2024 | 16 | — | 65.32M | $7.75B | — | — |
Quién lo tiene en cartera · Q2 2024
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 43.45M | — | $5.16B | 4.0% | n/c | 1 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 43.45M | — | $5.16B | 4.0% | n/c | 1 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 43.45M | — | $5.16B | 4.0% | n/c | 1 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 43.45M | — | $5.16B | 4.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 6.89M | — | $815.90M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 6.89M | — | $815.90M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.32M | — | $512.83M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.32M | — | $512.83M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 4.32M | — | $512.83M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 4.32M | — | $512.83M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 4.32M | — | $512.83M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 4.32M | — | $512.83M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Capital World Investors ✦ | 3.67M | — | $435.48M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (pasivo) | 3.35M | — | $397.91M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 1.60M | — | $189.97M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 1.60M | — | $189.97M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | ARK Investment Management ✦ | 1.05M | — | $125.17M | 1.1% | n/c | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 460.46K | — | $54.68M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Adage Capital Partners ✦ | 252.45K | — | $29.98M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 85.90K | — | $10.20M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 67.40K | — | $8.00M | 0.1% | n/c | 1 | SEC ↗ |
| 22 | Millennium Management ✦ | 49.20K | — | $5.84M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Marshall Wace ✦ | 35.20K | — | $4.18M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 19.38K | — | $2.30M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Bridgewater Associates ✦ | 15.31K | — | $1.82M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 5.08K | — | $603,586 | 0.0% | n/c | 1 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 5.08K | — | $603,586 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 717 tenedores, 306.78M acciones, $15.39B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q2 2024 ·
Metodología ·
Obtener esto a través de la API